Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis (HIT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Institut Curie
Sponsor:
Collaborators:
Hoffmann-La Roche
Centre Leon Berard
Groupe Hospitalier Pitie-Salpetriere
Centre Oscar Lambret
Centre Francois Baclesse
Institut Bergonié
University Hospital, Toulouse
Institut du Cancer de Montpellier - Val d'Aurelle
University Hospital, Grenoble
Information provided by (Responsible Party):
Institut Curie
ClinicalTrials.gov Identifier:
NCT01373710
First received: May 24, 2011
Last updated: July 8, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2019
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)